Get startedLog in
    Picture of Axsome Therapeutics logo

    AXSM — Axsome Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapFalling Star
    All News

    Axsome's drug for Alzheimer's disease agitation meets main goal in late-stage study

    Picture of Axsome Therapeutics logoAxsome Therapeutics
    30/12/2024 12:09
    Dec 30 (Reuters) - Axsome Therapeutics  AXSM.O  said on
Monday its experimental treatment for the Alzheimer's
disease-related agitation met the main goal of a late-stage
trial.

 (Reporting by Sneha S K; Editing by Shilpi Majumdar)
 ((Sneha.SK@thomsonreuters.com;))

    Recent news on Axsome Therapeutics

    See all news